Download the infographic to discover how Allucent’s experts integrate site feasibility and patient recruitment into a unified, patient-focused strategy to help oncology sponsors reach the right patients and improve overall trial outcomes.
Oncology trials are becoming increasingly complex, driven by more stringent eligibility criteria and rising competition for patients and sites. As a result, many sponsors face delays, under-enrollment, and increased pressure on timelines and budgets.
Traditional approaches to site feasibility and patient recruitment are no longer sufficient to ensure consistent enrollment success. A more integrated, patient-centered site feasibility strategy can help sponsors better predict enrollment, select the right sites, and engage the right patients from the outset.
This infographic explores how biopharma teams can:
- Improve enrollment predictability through patient pathway–driven site feasibility strategies
- Identify and activate high-performing sites faster by aligning selection with real-world patient access
- Enhance patient recruitment and retention with targeted, insight-led engagement approaches
- Reduce site burden and strengthen partnerships to drive long-term trial performance
- Accelerate study timelines while maintaining data quality and operational efficiency
For more information on site feasibility and the patient pathway model, watch the recording of our webinar, Smarter Site Feasibility Strategies for Predictable Enrollment in Late-Stage Oncology Trials.
Request a Proposal
Share This
